(Q55470131)

12 July 2018

title

Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas. (English)

1 reference

12 July 2018

author

Ian F. Parney

1

1 reference

12 July 2018

author name string

Lung-Ji Chang

2

1 reference

12 July 2018

Maxine A Farr-Jones

3

1 reference

12 July 2018

Chunhai Hao

4

1 reference

12 July 2018

Michael Smylie

5

1 reference

12 July 2018

Kenneth C Petruk

6

1 reference

12 July 2018

publication date

21 April 2006

1 reference

12 July 2018

Journal of Neuro-Oncology

published in

1 reference

12 July 2018

volume

78

1 reference

12 July 2018

page(s)

71-80

1 reference

12 July 2018

issue

1

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1007/s11060-005-9058-0

exact match

0 references

cites work

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-9058-0

CD28/B7 costimulation: a review

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-9058-0

Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study.

21 January 2018

1 reference

12 December 2020

Adjuvant interferon-alpha in malignant melanoma: current status

1 reference

12 December 2020

Glioma immunology and immunotherapy.

1 reference

12 December 2020

Interleukin-2 gene therapy in a patient with glioblastoma

1 reference

12 December 2020

Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.

1 reference

12 December 2020

Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial

1 reference

12 December 2020

Human gene marker/therapy clinical protocols (complete updated listing)

1 reference

12 December 2020

Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer

1 reference

12 December 2020

Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine

1 reference

12 December 2020

Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.

1 reference

12 December 2020

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

12 December 2020

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas

1 reference

12 December 2020

Retroviral vectors for gene therapy of AIDS and cancer

1 reference

12 December 2020

Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions

1 reference

12 December 2020

Improved technique for establishing short term human brain tumor cultures.

1 reference

12 December 2020

Gene gun transfection of human glioma and melanoma cell lines with genes encoding human IL-12 and GM-CSF.

1 reference

12 December 2020

Novel costimulators in the immune gene therapy of cancer

1 reference

12 December 2020

Treatment of malignant glioma in adults.

1 reference

12 December 2020

Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study.

1 reference

12 December 2020

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

Use of retroviral vectors for gene transfer and expression

1 reference

12 December 2020

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

1 reference

12 December 2020

Human brain tumor cell culture characterization after immunostimulatory gene transfer.

1 reference

12 December 2020

Modulation of T-cell function by gliomas

1 reference

12 December 2020

Prognosis and staging in melanoma

1 reference

12 December 2020

Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

1 reference

12 December 2020

Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.

1 reference

12 December 2020

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

12 December 2020

B7-1 gene-modified tumor cell vaccines.

1 reference

12 December 2020

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer

1 reference

12 December 2020

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.

1 reference

12 December 2020

A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model

1 reference

12 December 2020

Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.

1 reference

12 December 2020

T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.

1 reference

12 December 2020

A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo.

1 reference

12 December 2020

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

1 reference

12 December 2020

Immunological gene therapy with ex vivo gene-modified tumor cells: a critique and a reappraisal

1 reference

12 December 2020

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

1 reference

12 December 2020

Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma

1 reference

12 December 2020

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

1 reference

12 December 2020

Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12.

1 reference

12 December 2020

Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system

1 reference

12 December 2020

Interpreting cancer vaccine clinical trials

1 reference

12 December 2020

10.1007/S11060-005-9058-0

Identifiers

DOI

1 reference

12 July 2018

Dimensions Publication ID

0 references

1 reference

12 July 2018